Drug Profile
Raluridine
Alternative Names: 935U83; BW935U83; FCULatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antiretrovirals; Deoxyribonucleosides; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 24 Aug 1999 Discontinued-I for HIV infections treatment in Spain (PO)
- 24 Aug 1999 Discontinued-II for HIV infections treatment in USA (PO)
- 26 Feb 1997 A phase I study has been added to the pharmacokinetic section